Prognostic significance of neuroadrenergic dysfunction for cardiovascular events in patients with acute myocardial infarction

Circulation Journal

Volumn 79, Issue 10, 2015, Pages 2238-2245

  Minamisawa, Masatoshi ^a   Izawa, Atsushi ^a   Motoki, Hirohiko ^a   Kashima, Yuichiro ^a   Hioki, Hirofumi ^a   Abe, Naoyuki ^a   Miura, Takashi ^a   Ebisawa, Soichiro ^a   Miyashita, Yusuke ^a   Koyama, Jun ^a   Ikeda, Uichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; Autonomic nervous system; Blood pressure; Cardiovascular events

Indexed keywords

(3 IODOBENZYL) GUANIDINE I 123; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; CREATINE KINASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADRENAL DISEASE; AGED; ARTICLE; BLOOD PRESSURE METER; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIAC IMAGING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY OBSTRUCTION; EVOKED MUSCLE RESPONSE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HOFFMANN REFLEX; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; NEUROADRENERGIC DYSFUNCTION; PROGNOSTIC ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION; STENOSIS; BLOOD PRESSURE; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMPLICATION; HEART INFARCTION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RADIOGRAPHY; RISK ASSESSMENT; STROKE;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE;

EID: 84942515262     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0265     Document Type: Article

References (42)

1. Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging 2010; 3: 92–100
2. Shah AM, Bourgoun M, Narula J, Jacobson AF, Solomon SD. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure. JACC Cardiovasc Imaging 2012; 5: 1139–1146
3. Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging 2013; 6: 772–784
4. Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, et al. Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction. Heart 2011; 97: 20–26
5. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomic nervous function in non-dipper essential hypertensive subjects: Evaluation by power spectral analysis of heart rate variability. Hypertension 1995; 26: 808–814
6. Imai Y, Abe K, Miura Y, Nihei M, Sasaki S, Minami N, et al. Hypertensive episodes and circadian fluctuations of blood pressure in patients with phaeochromocytoma: Studies by long-term blood pressure monitoring based on a volume-oscillometric method. J Hypertens 1988; 6: 9–15
7. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801
8. Vasunta RL, Kesäniemi YA, Ylitalo A, Ukkola O. Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study. Am J Hypertens 2012; 25: 60–66
9. Kario K. Obstructive sleep apnea syndrome and hypertension: Ambulatory blood pressure. Hypertens Res 2009; 32: 428–432
10. Leńska-Mieciek M, Derecka-Charzyńska I, Fiszer U, Królicki L, Kułakowski P. Syncope and autonomic cardiovascular dysfunction in Parkinson disease. Neurol Neurochir Pol 2011; 45: 335–341
11. Kashima Y, Izawa A, Aizawa K, Koshikawa M, Kasai H, Tomita T, et al. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study. J Cardiol 2009; 54: 76–79
12. Izawa A, Kashima Y, Miura T, Ebisawa S, Kitabayashi H, Yamamoto H, et al. Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction: ALPS-AMI study. Circ J 2015; 79: 161–168
13. JCS Joint Working Group. Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): Digest version. Circ J 2012; 76: 508–519
14. Aso S, Yazaki Y, Kasai H, Takahashi M, Yoshio T, Yamamoto K, et al. Anti-beta 1-adrenoreceptor autoantibodies and myocardial sympathetic nerve activity in chronic heart failure. Int J Cardiol 2009; 131: 240–245
15. Merlet P, Valette H, Dubois-Randé JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471–477
16. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007; 116: 2634–2653
17. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–992
18. Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209: 278–282
19. Seo HS, Kang TS, Park S, Choi EY, Ko YG, Choi D, et al. Nondippers are associated with adverse cardiac remodeling and dysfunction (R1). Int J Cardiol 2006; 112: 171–177
20. Erdogan D, Gullu H, Caliskan M, Yildirim I, Baycan S, Ciftci O, et al. The influence of circadian blood pressure changes on aortic distensibility and left ventricular diastolic function in hypertensive individuals. Int J Cardiovasc Imaging 2006; 22: 157–165
21. Soylu A, Duzenli MA, Yazici M, Ozdemir K, Tokac M, Gok H. The effect of nondipping blood pressure patterns on cardiac structural changes and left ventricular diastolic functions in normotensives. Echocardiography 2009; 26: 378–387
22. Park CS, An GH, Kim YW, Park YJ, Kim MJ, Cho EJ, et al. Evaluation of the relationship between circadian blood pressure variation and left atrial function using strain imaging. J Cardiovasc Ultrasound 2011; 19: 183–191
23. Ijiri H, Kohno I, Yin D, Iwasaki H, Takusagawa M, Iida T, et al. Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension. Jpn Circ J 2000; 64: 499–504
24. Izzedine H, Launay-Vacher V, Deray G. Abnormal blood pressure circadian rhythm: A target organ damage? Int J Cardiol 2006; 107: 343–349
25. O’Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821–848
26. Soylu A, Yazici M, Duzenli MA, Tokac M, Ozdemir K, Gok H. Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circ J 2009; 73: 899–904
27. de la Sierra A, Gorostidi M, Banegas JR, Segura J, de la Cruz JJ, Ruilope LM. Nocturnal hypertension or nondipping: Which is better associated with the cardiovascular risk profile? Am J Hypertens 2014; 27: 680–687
28. Kurpesa M, Trzos E, Drozdz J, Bednarkiewicz Z, Krzemińska- Pakuła M. Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: Assessment of normotensive and hypertensive patients. Int J Cardiol 2002; 83: 133–142
29. Liu M, Takahashi H, Morita Y, Maruyama S, Mizuno M, Yuzawa Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 563–569
30. Nakano Y, Oshima T, Ozono R, Higashi Y, Sasaki S, Matsumoto T, et al. Non-dipper phenomenon in essential hypertension is related to blunted nocturnal rise and fall of sympatho-vagal nervous activity and progress in retinopathy. Auton Neurosci 2001; 88: 181–186
31. Morita Y, Maeda K, Kondo T, Ishii H, Matsudaira K, Okumura N, et al; Nagoya Acute Myocardial Infarction Study (NAMIS) Group. Impact of adiponectin and leptin on long-term adverse events in Japanese patients with acute myocardial infarction: Results from the Nagoya Acute Myocardial Infarction Study (NAMIS). Circ J 2013; 77: 2778–2785
32. Kimura S, Inagaki H, Haraguchi G, Sugiyama T, Miyazaki T, Hatano Y, et al. Relationships of elevated systemic pentraxin-3 levels with high-risk coronary plaque components and impaired myocardial perfusion after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction. Circ J 2014; 78: 159–169
33. Higuma T, Abe N, Tateyama S, Endo T, Shibutani S, Yokoyama H, et al. Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel prognostic biomarker in patients with ST-segment elevation acute myocardial infarction. Circ J 2015; 79: 641–648
34. Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, et al. Reproducibility and clinical value of nocturnal hypotension: Prospective evidence from the SAMPLE study: Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998; 16: 733–738
35. Kato B, Nozawa T, Igarashi N, Nonomura M, Fujii N, Igawa A, et al. Discrepant recovery course of sympathetic neuronal function and beta-adrenoceptors in rat hearts after reperfusion following transient ischemia. J Nucl Med 2004; 45: 1074–1080
36. Hattori N, Schwaiger M. Metaiodobenzylguanidine scintigraphy of the heart: What have we learnt clinically? Eur J Nucl Med 2000; 27: 1–6
37. Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995; 36: 969–974
38. Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies. J Nucl Cardiol 2004; 11: 126–133
39. Ebata H, Hojo Y, Ikeda U, Ishida H, Natsume T, Shimada K. Differential effects of an alpha 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res 1995; 18: 125–130
40. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1999; 100: 1635–1638
41. Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, et al. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens 2008; 26: 583–588
42. Balachandran KP, Oldroyd KG. Recovery of normal diurnal variation of blood pressure following renal artery stenting. J Hum Hypertens 2003; 17: 147–150.